Ascendis Pharma A/S vs Core Scientific Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Core Scientific Inc trades at $20.88 (market cap $6.35B). The key difference: Ascendis Pharma A/S is far larger — about 2.6× Core Scientific Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Core Scientific Inc nearer its low. Which is the better fit depends on your goals.
| ASND | CORZ | |
|---|---|---|
Market Cap | $16.67B | $6.35B |
Sector | Health | Technology |
52-Week High | $277.18 | $29.16 |
52-Week Low | $189.74 | $13.55 |
Enterprise Value | $17.04B | $8.88B |
Trailing returns across standard periods
Latest headlines on both assets
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →